1. As of noon trading, Agilent Technologies ( A) is up $0.26 (0.6%) to $44.88 on light volume Thus far, 800,143 shares of Agilent Technologies exchanged hands as compared to its average daily volume of 3.4 million shares. The stock has ranged in price between $44.68-$45.24 after having opened the day at $44.81 as compared to the previous trading day's close of $44.62.

Agilent Technologies, Inc. provides bio-analytical and electronic measurement solutions and services to the life sciences, chemical analysis, diagnostics and genomics, communications, and electronics industries worldwide. Agilent Technologies has a market cap of $15.5 billion and is part of the health care sector. The company has a P/E ratio of 13.6, below the S&P 500 P/E ratio of 17.7. Shares are up 8.9% year to date as of the close of trading on Tuesday. Currently there are 13 analysts that rate Agilent Technologies a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Agilent Technologies as a buy. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Agilent Technologies Ratings Report now.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE

If you are interested in one of these 5 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

A reminder about TheStreet Ratings group: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

null

If you liked this article you might like

Wall Street Weighs What's Next on Healthcare

Molina's Executive Shakeup Increases Possibility of Takeout

UnitedHealth Seen as Ready to Weather Obamacare Rewrite

UnitedHealth to Test Durability of 2017's Strong Start

Exxon, Thermo Fisher and 2 More Are Showing Red Flags